Advertisement
Canada markets close in 5 hours 15 minutes

  • S&P/TSX

    21,989.22
    +117.26 (+0.54%)
     

  • S&P 500

    5,060.89
    +50.29 (+1.00%)
     

  • DOW

    38,453.66
    +213.68 (+0.56%)
     

  • CAD/USD

    0.7320
    +0.0019 (+0.26%)
     

  • CRUDE OIL

    82.04
    +0.14 (+0.17%)
     

  • Bitcoin CAD

    91,221.00
    +621.75 (+0.69%)
     

  • CMC Crypto 200

    1,437.84
    +23.08 (+1.63%)
     

  • GOLD FUTURES

    2,334.60
    -11.80 (-0.50%)
     

  • RUSSELL 2000

    2,000.71
    +33.24 (+1.69%)
     

  • 10-Yr Bond

    4.5800
    -0.0430 (-0.93%)
     

  • NASDAQ

    15,662.32
    +211.02 (+1.37%)
     

  • VOLATILITY

    16.31
    -0.63 (-3.72%)
     

  • FTSE

    8,036.63
    +12.76 (+0.16%)
     

  • NIKKEI 225

    37,552.16
    +113.55 (+0.30%)
     

  • CAD/EUR

    0.6836
    -0.0014 (-0.20%)
     
MARKETS LIVE BLOG:

STOCKS EXTEND GAINS AS RESULTS SEASON KICKS INTO HIGH GEAR

Tech-focused investors prepare for fresh wave of earnings highlighted by struggling Tesla

Global Next-generation Sequencing Market Report 2020-2025 - Enhancing Regulatory Framework for Next-generation Sequencing Based Tests for Diagnostics Driving Growth

Research and Markets
·6 min read

Dublin, March 05, 2021 (GLOBE NEWSWIRE) -- The "Global Next-generation Sequencing Market, by Product (Consumables, Platforms and Services), by Technology (Sequencing by Synthesis, Ion Semiconductor Sequencing, and Other), by End User, by Application, by Region, Competition, Forecast & Opportunities, 2025" report has been added to ResearchAndMarkets.com's offering.

The Global Next-generation Sequencing Market was valued at USD 8206.75 Million in 2019 and is projected to grow at a CAGR of 19.59% during the forecast period.

Enhancing regulatory framework for next-generation sequencing based tests for diagnostics is the key factor for the growth of the Global Next-generation Sequencing Market during the forecast period.

Moreover, advancements in next-generation sequencing coupled with reduction in the price of NGS platforms are some other major factors that are anticipated to bolster the growth of the Global Next-generation Sequencing Market over the coming years. However, some of the factors that might act as major impediments to the growth of the Global Next-generation Sequencing Market includes concerns pertaining to the standards of NGS based diagnostics.

The Global Next-generation Sequencing Market is segmented based on product, technology, end-user, application, region and company. Based on technology, the market can be segmented into sequencing by synthesis, ion semiconductor sequencing, sequencing by ligation, single molecule real time sequencing and other technologies.

Among them, the sequencing by synthesis (SBS) segment dominated the market until 2019 with share of 73.04% and is projected to grow with a healthy CAGR over the forecast period due to development of new and advanced NGS platforms along with rising demand for Illumina's systems as it uses the SBS technology.

Major players operating in the Global Next-generation Sequencing Market include Illumina, Inc., Thermo Fisher Scientific, Inc, BGI Group, Perkinelmer Inc., Agilent Technologies, Inc., Pacific Biosciences of California Inc., F. Hoffmann-La Roche Ltd., 10x Genomics Inc., Amgen Inc., Takara Bio Inc. and others.

ADVERTISEMENT

Key Target Audience:

  • Next-generation sequencing service providers, vendors and other stakeholders

  • Government bodies such as regulating authorities and policy makers

  • Organizations, forums and alliances related to next-generation sequencing

  • Market research and consulting firms

Years considered for this report:

  • Historical Years: 2015-2018

  • Base Year: 2019

  • Estimated Year: 2020

  • Forecast Period: 2021-2025

Key Topics Covered:

1. Product Overview

2. Research Methodology

3. Impact of COVID-19 on Global Next-Generation Sequencing (NGS) Market

4. Executive Summary

5. Voice of Customer
5.1. By Brand Recall
5.2. By Preferred Technology
5.3. By Preferred Application

6. Global Next-Generation Sequencing (NGS) Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Product (Consumables, Platforms and Services)
6.2.1.1. By Consumables (Sample preparation consumables and Other Consumables)
6.2.1.2. By Platforms (HiSeq series, MiSeq series, ION Torrent, SOLiD, Pacbio Rs II and Sequel system, Other Sequencing Platforms)
6.2.1.3. By Services (Sequencing Services and Data management services)
6.2.2. By Technology (Sequencing by Synthesis, Ion Semiconductor Sequencing, Sequencing by Ligation, Single Molecule Real Time Sequencing and Other)
6.2.3. By End User (Academic & Clinical Research Centers, Pharmaceutical & Biotechnology Companies, Hospitals & Clinics and Others)
6.2.4. By Application (Biomarkers & Cancer, Diagnostics, Reproductive Health, Personalized Medicine, Agriculture & Animal Research and Others)
6.2.5. By Region
6.2.6. By Company (2019)
6.3. Product Market Map

7. North America Next-Generation Sequencing (NGS) Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Product
7.2.2. By Technology
7.2.3. By End User
7.2.4. By Application
7.2.5. By Country (United States; Canada; Mexico and Rest of North America)
7.3. North America: Country Analysis
7.3.1. United States Next-Generation Sequencing (NGS) Market Outlook
7.3.2. Canada Next-Generation Sequencing (NGS) Market Outlook
7.3.3. Mexico Next-Generation Sequencing (NGS) Market Outlook

8. Europe Next-Generation Sequencing (NGS) Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Product
8.2.2. By Technology
8.2.3. By End User
8.2.4. By Application
8.2.5. By Country (France; Germany; UK; Italy; Spain and Rest of Europe)
8.3. Europe: Country Analysis
8.3.1. France Next-Generation Sequencing (NGS) Market Outlook
8.3.2. Germany Next-Generation Sequencing (NGS) Market Outlook
8.3.3. United Kingdom Next-Generation Sequencing (NGS) Market Outlook
8.3.4. Italy Next-Generation Sequencing (NGS) Market Outlook
8.3.5. Spain Next-Generation Sequencing (NGS) Market Outlook

9. Asia-Pacific Next-Generation Sequencing (NGS) Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Product
9.2.2. By Technology
9.2.3. By End User
9.2.4. By Application
9.2.5. By Country (China; India; Japan; South Korea; Australia; and Rest of Asia Pacific)
9.3. Asia-Pacific: Country Analysis
9.3.1. China Next-Generation Sequencing (NGS) Market Outlook
9.3.2. India Next-Generation Sequencing (NGS) Market Outlook
9.3.3. Japan Next-Generation Sequencing (NGS) Market Outlook
9.3.4. South Korea Next-Generation Sequencing (NGS) Market Outlook
9.3.5. Australia Next-Generation Sequencing (NGS) Market Outlook

10. Middle East and Africa Next-Generation Sequencing (NGS) Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Product
10.2.2. By Technology
10.2.3. By End User
10.2.4. By Application
10.2.5. By Country (UAE; Saudi Arabia; South Africa and Rest of Middle East & Africa)
10.3. MEA: Country Analysis
10.3.1. South Africa Next-Generation Sequencing (NGS) Market Outlook
10.3.2. Saudi Arabia Next-Generation Sequencing (NGS) Market Outlook
10.3.3. UAE Next-Generation Sequencing (NGS) Market Outlook

11. South America Next-Generation Sequencing (NGS) Market Outlook
11.1. Market Size & Forecast
11.1.1. By Value
11.2. Market Share & Forecast
11.2.1. By Product
11.2.2. By Technology
11.2.3. By End User
11.2.4. By Application
11.2.5. By Country (Brazil; Argentina; Colombia; and Rest of South America)
11.3. South America: Country Analysis
11.3.1. Brazil Next-Generation Sequencing (NGS) Market Outlook
11.3.2. Argentina Next-Generation Sequencing (NGS) Market Outlook
11.3.3. Colombia Next-Generation Sequencing (NGS) Market Outlook

12. Market Dynamics
12.1. Drivers
12.2. Challenges

13. Market Trends & Developments

14. Competitive Landscape (NGS Platform Providers)
14.1. Competition Outlook
14.2. Company Profiles
14.2.1. Illumina, Inc.
14.2.2. Thermo Fisher Scientific, Inc
14.2.3. BGI Group
14.2.4. Perkinelmer Inc.
14.2.5. Agilent Technologies, Inc.
14.2.6. Pacific Biosciences of California Inc.
14.2.7. F. Hoffmann-La Roche Ltd.
14.2.8. 10x Genomics Inc.
14.2.9. Amgen Inc.
14.2.10. Takara Bio Inc.

15. Strategic Recommendations

For more information about this report visit https://www.researchandmarkets.com/r/274s4f

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900